Associate Director, Formulation & Process Development
Catalent
St. Petersburg, Florida
I am the Associate Director of Formulation and Process Development at Catalent St. Petersburg, where I lead a team of 35+ scientific and technical experts managing over 80 active pharmaceutical programs from pre-clinical through commercial stages. With deep expertise in lipid-based formulations and softgel technologies, I specialize in solving complex challenges related to bioavailability, solubility, and permeability. My work spans CMC strategy, early-phase development, and scale-up manufacturing through commercial launch. I’ve led cross-functional efforts supporting IND, NDA, ANDA, ANADA, and global regulatory submissions across Rx, OTC, and VMS portfolios. Over the course of my career, I’ve partnered with 100+ global clients, including top Pharma and Biotech companies, to accelerate timelines and de-risk development using innovative, practical formulation strategies.
Disclosure information not submitted.
Lipid-Based Formulations as Catalysts for Early-Phase Clinical Success
Monday, November 10, 2025
2:45 PM - 3:30 PM CT